APA (7th ed.) Citation

Mohamed, I. E. L., EL-Saeed, K. M., Al-Sadik, M. H., & Anwar, C. A. (2021). Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients. Egyptian Liver Journal, 11(1), 1. https://doi.org/10.1186/s43066-021-00089-5

Chicago Style (17th ed.) Citation

Mohamed, Inas E L-Khedr, Kadry Mohamed EL-Saeed, Mahmoud Hassan Al-Sadik, and Christina Alphonse Anwar. "Safety and Efficacy of Directly Acting Antivirals (sofosbuvir and Daclatasvir) in Treatment of Chronic HCV in HIV-HCV Co-infected Egyptian Patients." Egyptian Liver Journal 11, no. 1 (2021): 1. https://doi.org/10.1186/s43066-021-00089-5.

MLA (9th ed.) Citation

Mohamed, Inas E L-Khedr, et al. "Safety and Efficacy of Directly Acting Antivirals (sofosbuvir and Daclatasvir) in Treatment of Chronic HCV in HIV-HCV Co-infected Egyptian Patients." Egyptian Liver Journal, vol. 11, no. 1, 2021, p. 1, https://doi.org/10.1186/s43066-021-00089-5.